Novavax launches trial of coronavirus vaccine candidate
The firm has begun enrolling patients in the Phase I portion of the trial
Read More
Tag: NVX-CoV2373
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
